Sg Americas Securities, LLC Cullinan Oncology, Inc. Transaction History
Sg Americas Securities, LLC
- $30.5 Billion
- Q1 2025
A detailed history of Sg Americas Securities, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 16,636 shares of CGEM stock, worth $131,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,636
Previous 23,201
28.3%
Holding current value
$131,424
Previous $283,000
55.48%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CGEM
# of Institutions
152Shares Held
66.8MCall Options Held
41.1KPut Options Held
112K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$60.4 Million13.93% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$45.4 Million2.62% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$28 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$27 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$26.7 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $360M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...